Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MYM Nutraceuticals Inc MYMMF

Healthcare Drug Manufacturers - Major
MYM Nutraceuticals Inc is a Canada based company engaged in the business of acquiring and developing natural remedies. The company is focused on the medical marijuana business by producing cannabis growing facilities and products.


GREY:MYMMF - Post by User

MYM Nutraceuticals Inc > MYM Is Paying A Price For A Bad Deal
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Rhoda111on Apr 12, 2021 1:51pm
78 Views
Post# 32978371

RE:RE:RE:RE:RE:MYM Is Paying A Price For A Bad Deal

RE:RE:RE:RE:RE:MYM Is Paying A Price For A Bad DealI am pretty new to investing and need some clarification re what is happening. I had shares in BIOME Grow. Are they still good? any hope for increased value? Thanks..
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities